Across TCGA pan-cancer cohorts, MTND4P13 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MTND4P13’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where MTND4P13 RNA is repressed in tumor relative to normal tissue. In most cancer types MTND4P13 is over-expressed in tumor, although a few such as LIHC show the opposite, repressed pattern.

LIHC and KICH are the cancer types where MTND4P13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTND4P13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	−0.014	.001	6	view →
KICH	Female	All	+0.025	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MTND4P13 RNA expression & survival · all MTND4P13 data types